The IV iron therapy ferric bepectate is invented by the German company Serumwerk Bernburg, who will also be the producer of the API.
We aim to develop and market a new generation patented human injectable iron product based on ferric bepectate
About iron4u
Founded in Denmark in 2012 by investors from 5 European countries, iron4u’s main focus is to develop and register a new generation patented human injectable iron product based on ferric bepectate and to market the product world-wide. We are cooperating with the German company Serumwerk Bernburg and discussions with licensing partners are ongoing.
The company focuses on improving the treatment of iron deficiency for humans. In addition, iron4u have marketed products aiming at optimizing treatment of iron deficiency in the veterinary setting.
The vision
The vision of iron4u is to improve the care of iron deficiency and iron deficiency anemia through the development and introduction of new innovative iron therapy solutions – building on the vast amount of evidence and learnings from 50+ years of experience with oral and parenteral iron therapy.
Want to join us in our quest?
Our 5 guiding principles
1
The characteristics of the iron complex should minimize the risk of free iron in plasma
2
Iron complex size and binding strength should be designed to avoid urinary iron excretion
3
The iron complex design should promote fast removal of iron from plasma into the RES
4
Administration should be simple, securing convenience – and limiting dosing errors
5
Dextran related anaphylaxis should be avoided by using non-dextran-based carbohydrates
The mission
It is iron4u’s mission to introduce a new parenteral treatment solution for iron deficiency anemia that will solve some of the historical shortcomings of parenteral iron compounds, offering an attractive, well documented and cost-effective solution for combating iron deficiency anaemia in both rich and poor countries – we aim to change the future of IV iron.
In iron4u we have clear and passionate feelings about how global iron deficiency should be solved. We believe that no single initiative can stand alone but that it should be a coordinated effort covering below initiatives:
- Public education
- Nutritional supplementation
- Early diagnosis of conditions and diseases affecting iron balance
- By using oral iron, in the cases where the level of iron deficiency and expected medication adherence combined makes it a relevant clinical choice
- By timely and efficient use of well documented parenteral iron therapy solutions in cases where oral iron is not the optimal solution
The story so far
The team
The iron4u team consist of an experienced network of people in different pharma companies. Several team members have more than 20 years’ experience in the human and veterinarian injectable iron business. The team includes medical doctors, specialized in clinical pharmacology, clinical trial management and regulatory affairs.
Clinical development of ferric bepectate is currently conducted in cooperation with the German Fraunhofer Institute. Preclinical work is conducted in a cooperation with the following companies: Serumwerk Bernburg AG, Granzer Regulatory Consulting & Services from Munich, Oncodesign from Paris and Eurofins from Denmark.
c/o Lund Elmer Sandager Advokatpartnerselskab
Kalvebod Brygge 39, 5.
DK – 1560 Copenhagen V
+45 2532 1000